ArticlePlastic and reconstructive surgery. Global open2026
The Use of Kerecis Omega3 Wound Fish Skin Graft for the Treatment of Deep Burn Wounds.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Addressing deep partial-thickness burns (DPTBs) and full-thickness burns (FTBs) remains a significantly challenging task in modern burn surgery. Among a broad lineup of wound products, biological adjuncts like fish skin-derived scaffolds offer unique regenerative properties, presenting new possibilities in complex wound management. We herein report our institutional clinical experience with the fish skin-based scaffold Kerecis Omega3 Wound. Methods: This retrospective, single-center case series evaluated all patients with DPTBs and FTBs treated with Kerecis Omega3 Wound between 2020 and 2024 at the burn center of the University Hospital Zurich. The specific indications for intervention, depth of burn injury, anatomical regions of application, subsequent need for further surgery, and short- and long-term complications were systematically assessed. Results: Twenty-seven patients were reviewed, exhibiting a mean affected total body surface area of 35.73% and an average abbreviated burn severity index score of 7.74. Fish skin was used in an acute setting in 21 cases; for the remaining cases, it was used for chronic wound-healing disturbances following burn injury. The most frequently treated anatomical region was the upper extremity. Almost 50% of the DPTB wounds healed spontaneously following treatment with Kerecis Omega3 Wound. Conversely, all FTBs required further skin grafting or other reconstructive measures. Postsurgical infections occurred in 4 patients, necessitating the removal of the product. Contractures were observed in 3 patients with FTBs during clinical follow-up. Conclusions: Kerecis Omega3 Wound represents a valuable adjunct for wound conditioning in patients with DPTBs, either as a preparation before skin grafting or to stimulate spontaneous wound regeneration. Regarding FTBs, its efficacy in restoring the dermal layer requires further research and clinical validation.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.